Loading viewer...
investor_presentation
Format: PDF investor_presentation
Pieris Pharmaceuticals presents its pipeline of novel drug candidates including co-stim bispecifics and inhaled therapeutics leveraging its Anticalin platform technology. The presentation outlines the company's product development strategy, clinical programs, and potential market opportunities in respiratory and oncology indications.
investor_presentation
20 Pages
investor_presentation
27 Pages
Shelf Drilling
Iovance Biotherapeutics Investor Presentation — April 2019
investor_presentationinvestor_presentation
35 Pages
Iovance Biotherapeutics, Inc